Ondansetron Dosing for 19-Month-Old, 10.89 kg Child
For a 19-month-old child weighing 10.89 kg, administer ondansetron 0.15 mg/kg (approximately 1.6 mg) orally every 8 hours as needed for nausea and vomiting, with close monitoring for efficacy and adverse effects given the child's young age.
Dosing Rationale
The recommended dose is based on converging evidence from multiple sources:
Weight-based dosing: The most recent guideline 1 recommends 0.15 mg/kg every 8 hours for pediatric antiemetic use, which translates to approximately 1.6 mg per dose for this 10.89 kg child.
Age considerations are critical: This child at 19 months falls into a vulnerable age group. Pharmacokinetic data 2 demonstrates that ondansetron clearance is significantly reduced in infants, with a maturation half-life of approximately 4 months. Children younger than 6 months have 76% reduced clearance, and even at 6 months clearance remains 31% reduced. At 19 months, this child's clearance approaches adult levels but still warrants careful dosing.
FDA labeling 3 specifies that for children 4-11 years receiving chemotherapy, the dose is 4 mg three times daily. However, this child is younger than the FDA-approved age range for oral ondansetron, making weight-based dosing more appropriate.
Clinical Context Matters
The indication for ondansetron significantly influences the approach:
For Acute Gastroenteritis
- Single dose of 0.15 mg/kg has proven efficacy 4, 5
- Recent high-quality evidence 5 from 2025 shows that multidose ondansetron (up to 6 doses over 48 hours) reduces moderate-to-severe gastroenteritis compared to placebo
- Dose range of 0.13-0.26 mg/kg shows similar efficacy without increased side effects 6
For Chemotherapy-Induced Nausea
- Higher or more frequent dosing may be needed
- Evidence supports both single daily dosing (0.3 mg/kg) and divided dosing (0.15 mg/kg every 8 hours) 7
For Postoperative Nausea
- 0.05-0.15 mg/kg IV shows equivalent efficacy across this dose range 8
- FDA labeling does not support oral ondansetron for postoperative use in this age group 3
Practical Administration
For oral dosing in this 10.89 kg child:
- Calculate: 10.89 kg × 0.15 mg/kg = 1.6 mg per dose
- If using 4 mg tablets: Give approximately 0.4 of a 4 mg tablet (or use liquid formulation if available for more precise dosing)
- Maximum frequency: Every 8 hours
- Duration: Typically 24-48 hours for gastroenteritis; longer for chemotherapy-related nausea
Critical Safety Considerations
Monitor closely because:
- This child is younger than most studied populations in FDA trials 3
- Infants under 4 months require particularly close monitoring due to reduced clearance 2
- At 19 months, this child is past the highest-risk period but still warrants observation
Common pitfalls to avoid:
- Do NOT use the adult 8 mg dose - this would represent 0.73 mg/kg, nearly 5 times the recommended weight-based dose
- Do NOT exceed 0.15 mg/kg per dose in routine practice for this age
- Avoid combining with other sedating medications without appropriate monitoring 9
Adverse effects are generally mild:
- Headache, constipation, and diarrhea are most common
- QTc prolongation is rare but monitor if risk factors present
- No significant adverse effects were noted in pediatric studies at recommended doses 5, 7
Alternative Considerations
If ondansetron proves ineffective or contraindicated:
- Consider granisetron for CYP2D6 ultrarapid metabolizers 10
- Metoclopramide 0.1 mg/kg is an alternative, though less effective than ondansetron 1
- Dexamethasone 0.15 mg/kg can be added for refractory cases 1
The 0.15 mg/kg dose every 8 hours represents the optimal balance of efficacy and safety for this age and weight, supported by the most recent guideline evidence 1 and validated by pharmacokinetic studies in young children 2.